FIELD: organic chemistry, chemical technology, biochemistry, medicine.
SUBSTANCE: invention relates to novel isoquinoline compounds of the general formula (I):
wherein R1 represents hydrogen atom, halogen atom or alkyl; Y is absent or represents alkylene chain comprising from 1 to 8 carbon atoms wherein arbitrary carbon atom can comprise hydroxyl group as a substitute; R represents the following formula (II):
wherein X represents -CH or nitrogen atom under condition that if Y absent in the formula (I) then X must represent -CH; W represents -CH or nitrogen atom under condition that if X represents -CH then W must represents nitrogen atom; s represents a whole number from 1 to 3; t represents a whole number from 1 to 3; if R3 represents hydrogen atom or alkyl then R2 represents hydrogen atom, alkyl, hydroxyl group or hydroxyalkyl, and R2' represents hydroxyl group or hydroxyalkyl, and if R3 represents hydroxyalkyl then R2 and R2' represent hydrogen atom. Also, invention relates to their optically active forms, pharmaceutically acceptable salts, aqueous adducts, hydrates and solvates. Compounds of the formula (I) elicit inhibitory effect on activity of poly-(ADP-ribose)-polymerase and can be used in prophylaxis of diseases associated with cerebral infarction.
EFFECT: valuable medicinal properties of compounds, improved method of synthesis.
40 cl, 4 tbl, 55 ex
Title |
Year |
Author |
Number |
CYTOSKELETALLY ACTIVE RHO-KINASE INHIBITING COMPOUNDS, COMPOSITIONS AND USE THEREOF |
2007 |
- Lampe Dzhon V.
- Vatson Pol S.
- Slejd Dehvid Dzh.
- Piterson Uord M.
- Krin Kristofer S.
- Vittitou Dzhejson L.
- Dekamp Dzhonatan Brajan
- Pel'Ts Nikolas F.
|
RU2470928C2 |
SULFONAMIDE COMPOUND |
2006 |
- Jamada Rintaro
- Sehto Minoru
|
RU2376300C1 |
NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF |
2014 |
- Iguti Satoru
- Khosoj Fumikhito
- Sagara Takesi
|
RU2666349C2 |
HETEROCYCLIC COMPOUNDS |
2006 |
- Jamamoto Khirosi
- Okhe Jasukhiro
- Goto Khirojuki
- Kharada Kazukhito
- Jata Sindzi
- Nisiu Dzun
- Kakutani Makoto
- Fudzii Sunsuke
- Asakhina Kota
- Ito Takasi
|
RU2383539C2 |
AMINOPYRAZOLOPYRIMIDINE COMPOUND USED AS INHIBITOR OF TYROSINE KINASE RECEPTOR OF NEUROTROPHIC FACTOR |
2017 |
- Zhu Li
- Hu Yuandong
- Wu Wei
- Dai Liguang
- Duan Xiaowei
- Yang Yanqing
- Sun Yinghui
- Han Yongxin
- Peng Yong
- Kong Fansheng
- Luo Hong
- Yang Ling
- Xu Hongjiang
- Guo Meng
- Wang Shanchun
- Zhong Zhaobai
|
RU2764523C2 |
METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES |
2002 |
- Makichern Ehrnest Dzh.
- Bridzher Gari Dzh.
- Skupinska Kristina A.
- Skerldzh Renato T.
|
RU2308451C2 |
3,5-DISUBSTITUTED ALKYNYLBENZENE COMPOUND AND SALT THEREOF |
2013 |
- Sagara Takesi
- Ito Satoru
- Otsuki Satie
- Sootome Khirosi
|
RU2576384C1 |
COMPOUNDS OF 1-CYANO-PYRROLIDINES AS USP30 INHIBITORS |
2016 |
- Dzhons Elison
- Kemp Mark
- Stokli Martin
- Gibson Karl
- Uitlok Gevin
|
RU2717238C2 |
DERIVATIVES OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES AND RESPIRATORY WAYS DISEASES |
2001 |
- Bodkin Majkl
- Ehriksson Tomas
- Khansen Peter
- Khemmerling Martin
- Khenriksson Krister
- Klingstedt Tomas
- Pettersson Lars
|
RU2265011C2 |
POLYCYCLIC COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF POLYPEPTIDES OF FAST ACCELERATED FIBROSARCOMA |
2019 |
- Crew, Andrew P.
- Hornberger, Keith R.
- Wang, Jing
- Crews, Craig M.
- Jaime-Figueroa, Saul
- Dong, Hanqing
- Qian, Yimin
- Zimmerman, Kurt
|
RU2830173C2 |